Loading stock data…
$12.75+0.49 (+4.04%)
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States.
| Metric (USD) | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | $6.31M↓ | $7.22M↓ | $10.13M↑ | $8.82M |
| Gross Profit | — | — | — | — |
| Operating Income | -$71.61M↓ | -$64.11M↓ | -$60.15M↓ | -$48.15M |
| Net Income | -$67.25M↓ | -$61.45M↓ | -$52.43M↓ | -$41.69M |
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug...